Biology subjects

Spira, A.

Publications and source records attributed to Spira, A..

7 recordsLinked to original sources

bioRxiv2026

Molecular Determinants Governing the Antitubercular Activity of Griselimycin

The emergence of drug-resistant strains of Mycobacterium tuberculosis makes anti-tubercular drug development a critical priority. Griselimycin is a cyclic peptide that targets the essential DNA sliding clamp of M. tuberculosis. While griselimycin is a promising antimycobacterial compound, its poorly understood structure-activity relationship has stalled derivatization. To investigate the contribution of each amino acid towards its activity, we assessed the antibiotic activity of an alanine scan library in M. tuberculosis. Incorporation of an N-terminal fluorophore enabled visualization of griselimycin accumulation inside of mycobacteria-infected macrophage cells. Derivatives containing altered cyclization chemistries, unnatural amino acids, expanded proline side chains, and alkyne handles were assessed, with a final design combining the most potent edits showing increased antibiotic activity. These findings present the comprehensive structure-activity investigation of griselimycin and can be used to rationally design future analogues.

pharmacology and toxicology↗

bioRxiv2025

Split-luciferin Assay for Real-time Measurement of Cytosolic Drug Accumulation in Live Mycobacteria

Tuberculosis causes over one million deaths annually and remains the leading cause of death from a single infectious agent. The emergence of multidrug-resistant Mycobacterium tuberculosis strains highlights the urgent need for new antibiotics, a pursuit hindered by the bacteriums complex cell envelope. As most anti-tuberculosis agents act on intracellular targets, assessing cytosolic drug accumulation is critical. Conventional approaches generally quantify whole-cell association without resolving subcellular localization. Moreover, no current method permits real-time monitoring of drug accumulation in live mycobacterial cells. Here, we present a split-luciferin-based assay to quantify molecular accumulation in mycobacteria. Using this approach, we quantified the cytosolic accumulation of diverse small-molecule antibiotics and polyarginine peptides conjugated via a disulfide-linked D-cysteine tag. We also show the localization of a polyarginine peptide inside of mycobacteria in infected macrophage cells, demonstrating that these peptides can cross multiple accumulation barriers. Our findings establish the first assay for real-time quantification of cytosolic molecular accumulation in live mycobacteria, addressing a longstanding methodological gap and enabling mechanistic insights into intracellular drug uptake.

microbiology↗

bioRxiv2022

SnFFPE-Seq: towards scalable single nucleus RNA-Seq of formalin-fixed paraffin-embedded (FFPE) tissue

Profiling cellular heterogeneity in formalin-fixed paraffin-embedded (FFPE) tissues is key to characterizing clinical specimens for biomarkers, therapeutic targets, and drug responses. Here, we optimize methods for isolating intact nuclei and single nucleus RNA-Seq from FFPE tissues in the mouse brain, and demonstrate a pilot application to a human clinical specimen of lung adenocarcinoma. Our method opens the way to broad applications of snRNA-Seq to archival tissues, including clinical samples.

genomics↗

bioRxiv2020

Single-cell characterization of subsolid and solid lesions in the lung adenocarcinoma spectrum

Determining the clinical significance of CT scan-detected subsolid pulmonary nodules requires an understanding of the molecular and cellular features that may foreshadow disease progression. We studied the alterations at the transcriptome level in both immune and non-immune cells, utilizing single-cell RNA sequencing, to compare the microenvironment of subsolid, solid, and non-involved lung tissues from surgical resection specimens. This evaluation of early spectrum lung adenocarcinoma reveals a significant decrease in the cytolytic activities of natural killer and natural killer T cells, accompanied by a reduction of effector T cells as well as an increase of CD4+ regulatory T cells in subsolid lesions. Characterization of non-immune cells revealed that both cancer-associated alveolar type 2 cells and fibroblasts contribute to the deregulation of the extracellular matrix, potentially affecting immune infiltration in subsolid lesions through ligand-receptor interactions. These findings suggest a decrement of immune surveillance in subsolid lesions.

cancer biology↗

bioRxiv2018

Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution

The human bronchial epithelium is composed of multiple, distinct cell types that cooperate to perform functions, such as mucociliary clearance, that defend against environmental insults. While studies have shown that smoking alters bronchial epithelial function and morphology, the precise effects of this exposure on specific cell types are not well-understood. We used single-cell RNA sequencing to profile bronchial epithelial cells from six never- and six current smokers. Unsupervised analyses identified thirteen cell clusters defined by unique combinations of nineteen distinct gene sets. Expression of a set of toxin metabolism genes localized to ciliated cells from smokers. Smoking-induced airway remodeling was characterized by a loss of club cells and extensive goblet cell hyperplasia. Finally, we identified a novel peri-goblet epithelial subpopulation in smokers that expressed a marker of bronchial premalignant lesions. Our data demonstrates that smoke exposure drives a complex landscape of cellular and molecular alterations in the human bronchial epithelium that may contribute to the onset of smoking-associated lung diseases.

genomics↗

bioRxiv2017

Summarizing Performance for Genome Scale Measurement of miRNA: Reference Samples and Metrics

BackgroundThe potential utility of microRNA as biomarkers for early detection of cancer and other diseases is being investigated with genome-scale profiling of differentially expressed microRNA. Processes for measurement assurance are critical components of genome-scale measurements. Here, we evaluated the utility of a set of total RNA samples, designed with between-sample differences in the relative abundance of miRNAs, as process controls.\n\nResultsThree pure total human RNA samples (brain, liver, and placenta) and two different mixtures of these components were evaluated as measurement assurance control samples on multiple measurement systems at multiple sites and over multiple rounds. In silico modeling of mixtures provided benchmark values for comparison with physical mixtures. Biomarker development laboratories using next-generation sequencing (NGS) or genome-scale hybridization assays participated in the study and returned data from the samples using their routine workflows. Multiplexed and single assay reverse-transcription PCR (RT-PCR) was used to confirm in silico predicted sample differences. Data visualizations and summary metrics for genome-scale miRNA profiling assessment were developed using this dataset, and a range of performance was observed. These metrics have been incorporated into an online data analysis pipeline and provide a convenient dashboard view of results from experiments following the described design. The website also serves as a repository for the accumulation of performance values providing new participants in the project an opportunity to learn what may be achievable with similar measurement processes.\n\nConclusionsThe set of reference samples used in this study provides benchmark values suitable for assessing genome-scale miRNA profiling processes. Incorporation of these metrics into an online resource allows laboratories to periodically evaluate their performance and assess any changes introduced into their measurement process.

genomics↗

bioRxiv2017

Patterns of sedentary and active time accumulation are associated with mortality in US adults: The NHANES study

PurposeSedentary behavior has become a public health pandemic and has been associated with a variety of comorbidities including cardiovascular disease, type 2 diabetes, and some cancers. Previous studies have also shown that excessive amount of sedentary behavior is associated with all-cause mortality. However, no studies investigated whether patterns of sedentary and active time accumulation are associated with mortality independently of total sedentary and total active times. This study addresses this question by i) comparing several analytical ways to quantify patterns of both sedentary and active time accumulation through metrics of fragmentation of objectively-measured physical activity and ii) exploring the association of these metrics with all-cause mortality in a nationally representative US sample of elderly adults.\n\nMethodsThe accelerometry data of 3400 participants aged 50 to 84 in the National Health and Nutrition Examination Survey 2003-2006 cohorts were analyzed. Ten fragmentation metrics were calculated to quantify the duration of sedentary and active bouts: average bout duration, Gini index, average hazard, between-state transition probability, and the parameter of power law distribution. The association of these fragmentation metrics with all-cause mortality followed through December 31, 2011 was assessed with survey-weighted Cox proportional hazard models.\n\nResultsIn models adjusted for age, sex, race/ethnicity, education, body mass index, common comorbidities, and total sedentary/active time, four fragmentation metrics were associated with lower mortality risk: average active bout duration (HR=0.72 for 1SD increase, 95% CI = 0.590.88), Gini index for active bouts (HR = 0.75, 95% CI = 0.64-0.86), the parameter of power law distribution for sedentary bouts (HR = 0.75, 95% CI = 0.63-0.90), and sedentary-to-active transition probability (HR = 0.77, 95% CI = 0.61-0.96), and four fragmentation metrics were associated with higher mortality risk: the active-to-sedentary transition probability (HR = 1.40, 95% CI=1.23-1.58), the parameter of power law distribution for active bouts (HR = 1.33, 95% CI = 1.16-1.52), average hazard for durations of active bouts (HR = 1.32, 95% CI = 1.18-1.48), and average sedentary bout duration (HR =1.07, 95% CI = 1.01-1.13). After sensitivity analysis, average sedentary bout duration and sedentary-to-active transition probability became insignificant.\n\nConclusionLonger average duration of active bouts, a lower probability of transitioning from active to sedentary behavior, and a higher normalized variability of active bout durations were strongly negatively associated with all-cause mortality independently of total active time. A larger proportion of longer sedentary bouts were positively associated with all-cause mortality independently of total sedentary time. The results also suggested a nonlinear association of average active bout duration with mortality that corresponded to the largest risk increase in subjects with average active bout duration less than 3 minutes.

epidemiology↗